Total: $13,418.7M Company (Symbol)# Type Of Financing Number Of Shares, Units Or Warrants (M) Amount Raised ($M) Investors; Placement Agents; Details (Date) JANUARY Adherex Technologies Inc. (AMEX:ADH) Private placement of units 30.3U $10 Versant Partners Inc. agreed to purchase 30.3M units priced at 33 cents each; it also may buy an additional 45.5M units at the same price for additional proceeds of $15M; each unit consists of one common share and one-half of a common share purchase
State of the Industry Report | Sunday, July 18, 2010
Number of follow-on offerings in 2008: 20 Total raised in follow-ons in 2008: $2,155.61M Average value of follow-ons in 2008: $107.78M Company (Symbol) Date Filed Date Comm. Shares/ Units (M) Price Shares Out (M)@ Lead, Other Underwriters Gross (US$M) Post-Offering Market Cap (M)% JANUARY Orexigen Therapeutics Inc. (OREX) 1/7/08 1/24/08 7.326S $11 34.3 Merrill Lynch & Co. Leerink Swann LLC (co-lead) JMP Securities LLC Lazard Capital Markets Canaccord Adams Inc. Natixis
State of the Industry Report | Wednesday, July 14, 2010
Underwriter (Number of IPOs as Lead Underwriter/ Number of IPOs as Lead or Co-Manager) Percentage Change in Stock Price Post-IPO to Year-End Dawson James Securities (1/1)* -81% * Bioheart Inc. raised $5.8M in its IPO conducted in February. It was the only biotech IPO that raised money in the U.S. in 2008, and Dawson James Securities was the only underwriter that participated in the IPO.
State of the Industry Report | Tuesday, July 13, 2010
Underwriter (Number of IPOs as Lead Underwriter) Percentage Change in Stock Price from Offering to Year-End Dawson James Securities (1) -81% GunnAllen Financial (1) -91% MDB Capital Group LLC (1) -91%
State of the Industry Report | Tuesday, July 13, 2010
Underwriter (Number of IPOs as Lead Underwriter/ Number of IPOs As Lead Or Co-Manager) Percentage Change in Stock Price from Offering to Year-End Lehman Brothers Inc. (1/1) +28% Banc of America Securities (0/1) +9% Citigroup Global Markets (0/1) +9% Needham & Co. (0/1) -1% RBC Capital Markets (0/1) -1% William Blair & Co. LLC (0/1) -1% Rodman & Renshaw (1/2) -1% Merrill Lynch & Co. (4/4) -4% Cowen & Co. (0/1) -5% Friedman Billings Ramsey (0/1) -5%
State of the Industry Report | Tuesday, July 13, 2010
Underwriter (Number of IPOs as Lead Underwriter/ Number of IPOs As Lead Or Co-Manager) Percentage Change in Stock Price from Offering to Year-End Piper Jaffray (0/1) -5% JP Morgan Securities (4/6) -8% UBS Investments (4/4) -9% Goldman Sachs & Co. (2/4) -17% Morgan Stanley & Co. (1/3) -17% Lazard Capital Markets (0/4) -19% Deutsche Bank Securities (3/3) -28% Leerink Swann LLC (1/3) -30% Oppenheimer & Co. Inc. (0/1) -31% JMP Securities LLC (0/1) -49% Pacific Growth
State of the Industry Report | Tuesday, July 13, 2010
(in Millions of Dollars) Public Offerings January 413.6 February 689.9 March 89.9 April 0.0 May 99.9 June 177.3 July 12.8 August 546.0 September 219.9 October 0.0 November 0.0 December 0.0 Total 2,249.3 Public/Other January 352.0 February 578.3 March 277.3 April 532.2 May 422.6 June 310.4 July 475.9 August 408.4 September 349.1 October 388.2 November 274.3 December 334.7 Total 4,703.6 Private Biotechs January 336.8 February 244.9 March
State of the Industry Report | Tuesday, July 13, 2010
U.S. Public Follow-On Stock Offerings Company Offering Month Offering Price 12/31/08 Close Percent Change Acorda Therapeutics Inc. (ACOR) February $21.50 $20.51 -5% Acorda Therapeutics Inc. (ACOR) August $28.50 $20.51 -28% Allos Therapeutics Inc. (ALTH) May $5.64 $6.12 +9% Biodel Inc. (BIOD) February $15.50 $4.82 -69% Epicept Corp. (EPCT) March $0.92 $0.64 -30% Illumina Inc. (ILMN) August $87.50 $26.05 -70% Incyte Corp. (INCY) August $9 $3.79 -58% La Jolla Pharmaceutical Co. (LJPC
State of the Industry Report | Tuesday, July 13, 2010
Initial Public Offerings on U.S. Markets Company Offering Month Offering Price 12/31/08 Close Percent Change Bioheart Inc. (BHRT February $5.25 $0.99 -81% Average Change: -81%
State of the Industry Report | Tuesday, July 13, 2010
Number of IPOs in 2008: 3 Total raised in IPOs in 2008: $93.7M Average value of IPOs in 2008: $31.2M Company (Symbol) Date Filed Date Comm. Shares/Units (M) Price Shares Out (M)@ Lead, Other Underwriters Gross (US$M) Post-Offering Market Cap (M)% JANUARY Bioheart Inc. (BHRT) 2/13/07 2/20/08 1.1S $5.25 14.4 Dawson James Sec. $5.8 $75.6 MARCH BHK Inc. (Korea; LSE:BHKI) 3/19/08 3/19** N/A N/A N/A N/A $0 N/A MolMed SpA (Italy; MIL:MLM) 2/20/08 3/5** 26.1S €2.15 N/A N/A €50.1 ($76) N/A
State of the Industry Report | Tuesday, July 13, 2010
Total: $13,418.7M Company (Symbol)# Type Of Financing Number Of Shares, Units Or Warrants (M) Amount Raised ($M) Investors; Placement Agents; Details (Date) JANUARY Adherex Technologies Inc. (AMEX:ADH) Private placement of units 30.3U $10 Versant Partners Inc. agreed to purchase 30.3M units priced at 33 cents each; it also may buy an additional 45.5M units at the same price for additional proceeds of $15M; each unit consists of one common share and one-half of a common share purchase